Posts Tagged ‘pharmaceutical’

« Older Entries |

NDP and Greens Push Trudeau to Answer Vancouver’s Call to Decriminalize Drugs

Monday, December 28th, 2020

The MPs want Hajdu to use her authority under Section 56 of the act, which grants the health minister the power to issue an exemption from any part of the legislation “for a medical or scientific purpose or is otherwise in the public interest.” … to take the supply “out of the hands of criminals and remove the stigmatization, and ensure that people get access to safe, regulated, properly packaged products. And we need to substantially beef up our prevention, education and, most importantly, treatment options for substance users.

Tags: , , , ,
Posted in Health Policy Context | No Comments »


Premiers call dibs on federal money before it’s all spent

Friday, December 11th, 2020

Health care is provincial jurisdiction. They can levy taxes like Ottawa. If they need more money, they could raise taxes… A lot of what Ottawa does is sending money to people or provinces. But health care? … Mr. Trudeau doesn’t want to just send cheques. He wants to say he paid for something new and specific that Canadians want. He told the premiers that Ottawa might fund better long-term care, or pharmacare.

Tags: , , , , ,
Posted in Governance Debates | No Comments »


We need a homegrown solution for making enough vaccines for every Canadian 

Thursday, December 3rd, 2020

… pandemic preparedness… includes, at its core, an arms-length national vaccine manufacturing facility that, first and foremost, has the capacity to produce enough vaccines for every Canadian… The facility could be made available to the private sector to make large batches at cost during normal times and commandeered by the federal government for large-scale vaccine deployment during a pandemic… It would be a partnership between biopharmaceutical companies, academia and the federal government.

Tags: , , , , ,
Posted in Health Policy Context | No Comments »


When Canada was a world leader in vaccine research and production

Thursday, December 3rd, 2020

… scientists are permitted to take out patents on the products they develop (with our money), and then sell them to pharmaceutical manufacturers, who sell the products to the public — often at great profit. Even though our public investment paid for the original research, Canadians have no say over the products nor the price at which they are sold to us as consumers. Canada also has no share in the profits. We’ve ventured a long way, unfortunately, from the days when we had a publicly owned and medically innovative enterprise that dazzled on the world stage and kept Canadians at the front of the line for vaccines.

Tags: , , , ,
Posted in Health History | No Comments »


Let’s make Canada a global leader in COVID-19 treatments 

Tuesday, November 24th, 2020

Canadian-led breakthroughs in medical sciences can improve our health and well-being, bolster our universities and research hospitals, strengthen our reputation in the global competition for resources and talent, and result in economic benefits for Canadians. And, most importantly, these trials could quickly develop novel therapies for treating COVID-19 while creating the downstream benefits of infrastructure and know-how to help us discover treatments for the next pandemic as well as for other diseases.

Tags: , , , ,
Posted in Health Policy Context | No Comments »


Pharmaceutical industry offers Ottawa $1-billion to scrap pending drug pricing rules, documents show

Monday, November 16th, 2020

The pharmaceutical industry has made a last-ditch $1-billion proposal to the Canadian government in hopes of fending off parts of a drug pricing crackdown set to go into effect on Jan. 1… to boost local manufacturing and commercialization, and on new programs to improve access to drugs for rare diseases… “The position of the Government of Canada remains unchanged – Canada has among the highest patented medicine prices in the world, and these high prices negatively affect the ability of patients to access new medicines”

Tags: , , , , ,
Posted in Health Policy Context | No Comments »


Medicare 2.0: Fixing Holes in our healthcare system that hurt Canadians

Sunday, October 11th, 2020

Each wave of the pandemic reignites concerns about the state of long-term care homes and renews existing calls to improve our healthcare system… This research paper urges the government to expand public health care and outlines why it is critical to do so now, during COVID-19, calling for establishing comprehensive mental health services, making long-term care part of medicare, and implementing universal pharmacare now.

Tags: , , , , , , ,
Posted in Health Policy Context | No Comments »


Should we spend more on health? Only if we get better care 

Tuesday, September 22nd, 2020

… what the premiers are proposing is that the feds absorb some of their current spending. They want Ottawa to transfer money rather than use their own powers of taxation to increase revenues… This pandemic, more than anything, has exposed the shortcomings in health and welfare systems, particularly in caring for elders and other marginalized groups. That’s what we need to fix. The last thing we need is buck-passing.

Tags: , , , , ,
Posted in Health Debates | No Comments »


New survey shows Canadians want lasting change to accompany economic recovery

Tuesday, September 22nd, 2020

… change should be “fundamental.” … most often cited… is the need to reduce inequality… a priority shared by the higher and lower income alike… in a society that provides quality long-term care for the elderly, that covers all essential medicines through public drug plans, that makes sure employees can take paid sick days when they need to, and that makes affordable and high-quality daycare for young children available to all parents who need it.

Tags: , , , , , ,
Posted in Governance Debates | No Comments »


What is it that Doug Ford doesn’t understand about pharmacare?

Sunday, September 20th, 2020

The premiers keep complaining about rising health-care costs, so why not embrace the one big idea that could control costs dramatically? COVID-19 is a time of crisis, but it also confers an economic opportunity for health care… Money need not be an obstacle, because a well-designed plan will pay dividends — not just in lower drug costs but in better health outcomes.

Tags: , , , , , , ,
Posted in Health Debates | No Comments »


« Older Entries |